An important component of tissue engineering (TE) is the supporting matrix upon which cells
and tissues grow, also known as the scaffold. Scaffolds must easily integrate with host tissue …

The application of stem cells in regenerative and reparative therapies is emerging in
surgery. Published information can lead to an over simplified view of stem cells with respect …

Amniotic epithelial cells develop from the epiblast by 8 days after fertilization and before
gastrulation, opening the possibility that they might maintain the plasticity of pregastrulation …

Human embryonic stem cells (HESC) can potentially generate every body cell type, making
them excellent candidates for cell-and tissue-replacement therapies. HESC are typically …

The amnion is the inner of two membranes surrounding the fetus. That it arises from
embryonic epiblast cells prior to gastrulation suggests that it may retain a reservoir of stem …

Amniotic epithelium is derived from the epiblast by approx 8 d after fertilization. Other parts
of the placenta are derived from extraembryonic tissue. In addition to this developmental …

The greatest therapeutic promise of human embryonic stem cells (hESC) is to generate
specialized cells to replace damaged tissue in patients suffering from various degenerative …

Over the past two decades, human embryonic stem cells (hESCs) have gained attention due
to their pluripotent and proliferative ability which enables production of almost all cell types …

Hematopoietic stem cells (HSCs) are responsible for the life-long production of the blood
system and are pivotal cells in hematologic transplantation therapies. During mouse and …

Human embryonic stem (hES) cells are typically maintained on mouse embryonic fibroblast
(MEF) feeders or with MEF-conditioned medium. However, these xenosupport systems …